|
| 2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)propanoate Basic information |
Product Name: | 2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)propanoate | Synonyms: | 2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)propanoate;ethyl 2-Methyl-2-(4-(4;ethyl 2-Methyl-2-(4-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)propanoate;1H-Pyrazole-1-acetic acid, α,α-dimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-, ethyl ester;ethyl 2-methyl-2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]propanoate | CAS: | 1201657-32-0 | MF: | C15H25BN2O4 | MW: | 308.18 | EINECS: | | Product Categories: | | Mol File: | 1201657-32-0.mol | ![2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)propanoate Structure](CAS/GIF/1201657-32-0.gif) |
| 2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)propanoate Chemical Properties |
Boiling point | 406.2±25.0 °C(Predicted) | density | 1.08±0.1 g/cm3(Predicted) | pka | 1.53±0.10(Predicted) |
| 2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)propanoate Usage And Synthesis |
Uses | Ethyl 2-Methyl-2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)propanoate is used as a reactant in the preparation of inhibitors that overcome the G1202R anaplastic lymphoma kinase resistance mutation. |
| 2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)propanoate Preparation Products And Raw materials |
|